These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 36473763

  • 1. Efficacy of Levosimendan in the Treatment of Patients With Severe Septic Cardiomyopathy.
    Sun T, Zhang N, Cui N, Wang SH, Ding XX, Li N, Chen N, Yu ZB.
    J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):344-349. PubMed ID: 36473763
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
    Meng JB, Hu MH, Lai ZZ, Ji CL, Xu XJ, Zhang G, Tian S.
    Med Sci Monit; 2016 May 03; 22():1486-96. PubMed ID: 27138236
    [Abstract] [Full Text] [Related]

  • 3. [Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock].
    Fang M, Dong S.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct 03; 26(10):692-6. PubMed ID: 25315937
    [Abstract] [Full Text] [Related]

  • 4. [The effects of levosimendan on the cardiac function and prognosis in elderly patients with septic shock and myocardial contractility impairment].
    Xu CX, Li L, Gong SJ, Yu YH, Yan J.
    Zhonghua Nei Ke Za Zhi; 2018 Jun 01; 57(6):423-428. PubMed ID: 29925127
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
    Bhattacharjee S, Soni KD, Maitra S, Baidya DK.
    J Clin Anesth; 2017 Jun 01; 39():67-72. PubMed ID: 28494911
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of levosimendan and dobutamine on reducing peripheral blood interleukin-6 levels and improving cardiac function in patients with septic cardiomyopathy: a comparative study.
    Sun T, Sun QL, Liu Y, Zhang YY, Sheng P, Cui N, Zhang N, Wang SH, Su D.
    J Physiol Pharmacol; 2024 Aug 01; 75(4):. PubMed ID: 39415525
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
    Zangrillo A, Putzu A, Monaco F, Oriani A, Frau G, De Luca M, Di Tomasso N, Bignami E, Lomivorotov V, Likhvantsev V, Landoni G.
    J Crit Care; 2015 Oct 01; 30(5):908-13. PubMed ID: 26093802
    [Abstract] [Full Text] [Related]

  • 8. Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.
    Chang W, Xie JF, Xu JY, Yang Y.
    BMJ Open; 2018 Mar 30; 8(3):e019338. PubMed ID: 29602841
    [Abstract] [Full Text] [Related]

  • 9. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P.
    Intensive Care Med; 2005 May 30; 31(5):638-44. PubMed ID: 15812624
    [Abstract] [Full Text] [Related]

  • 10. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr 30; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study.
    Kandasamy A, Simon HA, Murthy P, Annadurai M, Ali MM, Ramanathan G.
    Ann Card Anaesth; 2017 Apr 30; 20(2):200-206. PubMed ID: 28393781
    [Abstract] [Full Text] [Related]

  • 12. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
    Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T.
    Crit Care Med; 1999 Sep 30; 27(9):1708-13. PubMed ID: 10507587
    [Abstract] [Full Text] [Related]

  • 13. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
    Huang L, Weil MH, Tang W, Sun S, Wang J.
    Crit Care Med; 2005 Mar 30; 33(3):487-91. PubMed ID: 15753736
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis.
    Liu DH, Ning YL, Lei YY, Chen J, Liu YY, Lin XF, Yang ZQ, Xian SX, Chen WT.
    Sci Rep; 2021 Oct 13; 11(1):20333. PubMed ID: 34645892
    [Abstract] [Full Text] [Related]

  • 15. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.
    Can J Cardiol; 2009 Oct 13; 25(10):e353-6. PubMed ID: 19812809
    [Abstract] [Full Text] [Related]

  • 16. A Meta-Analysis of the Effects of Levosimendan on Cardiac Function and Outcomes in Patients with Sepsis.
    Ma Z, Jin H, Liu F, Wang S, Huang P, Fang X.
    Altern Ther Health Med; 2023 Nov 13; 29(8):668-673. PubMed ID: 37678873
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study.
    Lancet; 2002 Jul 20; 360(9328):196-202. PubMed ID: 12133653
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.
    Eur J Cardiothorac Surg; 2009 Dec 20; 36(6):1024-30. PubMed ID: 19592266
    [Abstract] [Full Text] [Related]

  • 19. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G.
    Eur J Heart Fail; 2003 Jan 20; 5(1):101-8. PubMed ID: 12559222
    [Abstract] [Full Text] [Related]

  • 20. Meta-Analysis of the Efficacy of Levosimendan in the Treatment of Severe Sepsis Complicated with Septic Cardiomyopathy.
    Guan Q, Zhang C, Li B, Huang D, Li A, Qin J, Zhang X.
    Heart Surg Forum; 2023 Oct 30; 26(5):E609-E620. PubMed ID: 37920078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.